Stay updated on Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.

Latest updates to the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRemoved the lay language results summary, sponsor attribution (Ipsen), and the 'Helpful Links Provided by' section from the Study Details page.SummaryDifference0.1%

- Check17 days agoChange DetectedAdded a new site revision tag (v3.4.2) and removed an older government-funding notice and the previous revision tag (v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check25 days agoChange DetectedAdded a prominent notice about a lapse in government funding and potential update delays. Updated the page revision metadata to v3.4.1 with recent dates.SummaryDifference0.5%

- Check32 days agoChange DetectedShow glossary is now displayed; the labels were updated to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and the revision tag updated to 'Revision: v3.4.0', replacing the previous 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check46 days agoChange DetectedThe page shows a revision update from v3.3.3 to v3.3.4; no user-visible changes to study details or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check67 days agoChange DetectedFooter updates include Revision: v3.3.3; the HHS Vulnerability Disclosure link and Revision: v3.3.2 text were removed.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in RCC After Checkpoint Inhibitors Clinical Trial page.